Pharma

Beijing has cracked down on exports of the addictive painkilling drug fentanyl, but peptide exports seem to have a relatively free run. China should act against grey market supplies before they spell another opioid type crisis.

Revised CDSCO guidance mandates online applications, stricter registration norms for overseas manufacturers and digital compliance through the SUGAM portal.

The company, which is among the world’s top biosimilars manufacturers, remains in a wait-and-watch mode, while exploring partnerships for manufacturing in the US if required, Shaw said.

Natco claims the new patent unlawfully extends Novartis’s market monopoly over the breast cancer medicine past 2027; Delhi High Court issues notices to all parties.

India formulations and innovative medicines drive growth in Q1FY27, with management reiterating FY27 guidance. Margins face near-term pressure from investments and the Organon acquisition.

China's enforcement of mandatory inspections for foreign generic drug makers could impose new challenges for India's pharmaceutical industry.

In itself, Maharashtra's order to promote customer choice in buying medicines won’t help reduce bills or ensure safety. Trade margins are large and not all chemists have the right drugs safely stored. Yet, hospitals should welcome the move.

A core strength of India's pharmaceutical industry is its global reputation for reliability. For India to remain the 'pharmacy of the world,’ the sector must focus on production dependability in the face of rising climate risks.

This American pharma major wants to end its nightmare of lawsuits over allegations of ovarian cancer-causing talcum powder. But its therapeutic advances—in oncology, especially—might determine whether it can rescue J&J as a brand.